Predictors of exercise capacity following septal myectomy in patients with hypertrophic cardiomyopathy

被引:15
|
作者
Smith, Joshua R. [1 ]
Layrisse, Veronica [1 ,2 ]
Medina-Inojosa, Jose R. [1 ]
Berg, Jessica D. [1 ]
Ommen, Steve R. [1 ]
Olson, Thomas P. [1 ]
机构
[1] Mayo Clin, Dept Cardiovasc Med, 200 First St SW, Rochester, MN 55901 USA
[2] San Juan Bautista Sch Med, Caguas, PR USA
基金
美国国家卫生研究院;
关键词
Functional tolerance; oxygen uptake; hypertrophic cardiomyopathy; septal reduction surgery; LEFT-VENTRICULAR OUTFLOW; OBSTRUCTIVE CARDIOMYOPATHY; SYMPTOMATIC PATIENTS; SURGICAL MYECTOMY; MYOTOMY-MYECTOMY; SURVIVAL; ECHOCARDIOGRAPHY; MANAGEMENT; PROGNOSIS; ABLATION;
D O I
10.1177/2047487319898106
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Patients with hypertrophic obstructive cardiomyopathy (HOCM) have impaired exercise capacity. The gold standard therapy for patients with HOCM is septal myectomy surgery; however, changes in maximum oxygen uptake (VO(2)peak) following myectomy are variable, with VO(2)peak decreasing in some patients. Therefore, we evaluated changes in VO(2)peak following surgical myectomy to determine clinical predictors of those exhibiting decreased VO(2)peak post-myectomy. Methods HOCM patients (N = 295) who performed symptom limited cardiopulmonary exercise testing prior to and following surgical myectomy were included for analysis. The VO(2)peak non-responder group (n = 128) was defined as <0% change in VO(2)peak from pre- to post-myectomy. Step-wise regression models using demographics, clinical, and physiologic characteristics were created to determine predictors of hypertrophic cardiomyopathy patients in the VO(2)peak non-responder group. Results Independent predictors of the VO(2)peak non-responder group included higher pre-myectomy VO(2)peak (% predicted), older age, women, history of dyslipidemia, lack of cardiac rehabilitation enrollment, and lower body mass index (all p < 0.03). Forty-three (14.6%) patients reached the primary end-point of all-cause mortality during a median follow up of 11.25 years (interquartile range 6.94 to 16.40). After adjustment for age, sex, beta-blocker use, coronary artery disease history, and body mass index, the VO(2)peak non-responder group had greater risk of death compared with the VO(2)peak responder group (adjusted hazard ratio: 1.77, 95% confidence interval: 1.06-3.34, p = 0.01). Conclusion This large hypertrophic cardiomyopathy cohort demonstrated that demographic (i.e. female sex), lack of cardiac rehabilitation enrollment, and cardiovascular risk factors (i.e. history of dyslipidemia) are predictive of those patients that did not exhibit increases in VO(2)peak following septal myectomy surgery.
引用
收藏
页码:1066 / 1073
页数:8
相关论文
共 50 条
  • [1] PREDICTORS OF EXERCISE CAPACITY AFTER SEPTAL MYECTOMY IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
    Layrisse, Veronica
    Medina-Inojosa, Jose
    Van Iterson, Erik
    Smith, Joshua
    Olson, Thomas
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 733 - 733
  • [2] Predictors of Exercise Capacity Following Septal Myectomy Surgery in Hypertrophic Obstructive Cardiomyopathy in Men and Women
    Smith, Joshua R.
    Medina-Inojosa, Jose R.
    Olson, Thomas P.
    [J]. JOURNAL OF WOMENS HEALTH, 2022, 31 (10) : A10 - A10
  • [3] Sex Differences in Exercise Capacity Following Septal Myectomy Surgery in Patients With Hypertrophic Obstructive Cardiomyopathy
    Smith, Joshua R.
    Medina-Inojosa, Jose
    Layrisse, Veronica
    Olson, Thomas P.
    [J]. CIRCULATION, 2018, 138
  • [4] Exercise Echocardiography following Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy
    Noven, Johan
    Stagmo, Martin
    Wierup, Per
    Nozohoor, Shahab
    Bjursten, Henrik
    Sjogren, Johan
    Zindovic, Igor
    Ragnarsson, Sigurdur
    [J]. THORACIC AND CARDIOVASCULAR SURGEON, 2022, 70 (01): : 18 - 25
  • [5] HYPERTROPHIC CARDIOMYOPATHY AND SEPTAL MYECTOMY
    CHILD, JS
    CABEEN, WR
    ROBERTS, NK
    [J]. WESTERN JOURNAL OF MEDICINE, 1979, 130 (05): : 472 - 475
  • [6] Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy
    Cui, Hao
    Schaff, Hartzell, V
    Wang, Shuiyun
    Lahr, Brian D.
    Rowin, Ethan J.
    Rastegar, Hassan
    Hu, Shengshou
    Eleid, Mackram F.
    Dearani, Joseph A.
    Kimmelstiel, Carey
    Maron, Barry J.
    Nishimura, Rick A.
    Ommen, Steve R.
    Maron, Martin S.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (17) : 1647 - 1655
  • [7] CARDIOPULMONARY EXERCISE TEST IN PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY UNDERGOING SEPTAL MYECTOMY
    Cui, Hao
    Schaff, Hartzell
    Nishimura, Rick
    Geske, Jeffrey
    Dearani, Joseph
    Sun, Daokun
    Ommen, Steve
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 535 - 535
  • [8] EXERCISE PERFORMANCE AFTER SEPTAL MYOTOMY AND MYECTOMY IN PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
    REDWOOD, DR
    GOLDSTEIN, RE
    HIRSHFELD, J
    BORER, JS
    MORGANROTH, J
    MORROW, AG
    EPSTEIN, SE
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1979, 44 (02): : 215 - 220
  • [9] Outcome of septal myectomy in patients with hypertrophic obstructive cardiomyopathy
    Havndrup, O
    Pettersson, G
    Kjeldsen, K
    Bundgaard, H
    [J]. SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2000, 34 (06) : 564 - 569
  • [10] Septal myectomy for patients with hypertrophic cardiomyopathy: A new paradigm
    Nishimura, Rick A.
    Schaff, Hartzell V.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2016, 151 (02): : 303 - 304